Trials / Conditions / Abruptio Placentae
Abruptio Placentae
7 registered clinical trials studyying Abruptio Placentae.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Spanish Registry of Pregnant Women With COVID-19 NCT04558996 | Puerta de Hierro University Hospital | — |
| Terminated | Plasma Concentration of Biological Markers in Placental Abruption NCT03782168 | University of Arkansas | — |
| Withdrawn | Progesterone for First Trimester Vaginal Bleeding NCT01501890 | Soroka University Medical Center | N/A |
| Terminated | The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta NCT01279369 | Winthrop University Hospital | — |
| Completed | Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnanc NCT01068795 | HaEmek Medical Center, Israel | N/A |
| Completed | Magnesium Sulfate vs Placebo for Placental Abruption NCT00186069 | Stanford University | N/A |
| Completed | Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial) NCT00014989 | The George Washington University Biostatistics Center | Phase 3 |